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Summary
Dendritic cells (DC) can provide all the known costimulatory signals required for activation
of unprimed T cells and are the most efficient and perhaps the critical antigen presenting cells
in the induction of primary T cell-mediated immune responses. It is now shown that mouse
cell lines with many of the features of DC can be generated using the MIB~2-N11 retroviral
vector transducing a novel envAKR-mycmH' fusion gene. The immortalized dendritic cell line
(CBI) displays most of the morphologic, immunophenotypic, and functional attributes of DC,
including constitutive expression ofmajor histocompatibility complex (MHC) class II molecules,
costimulatory molecules B7/BB1, heat stable antigen, intracellular adhesion molecule 1, and efficient
antigen-presenting ability. Granulocyte/macrophage colony-stimulating factor (GM-CSF) proved
to be effective in increasing MHC class II molecule expression and in enhancing presentation
of native protein antigens. In comparison with macrophages, CB1 dendritic cells did not exhibit
phagocytic and chemotactic activity in response to various stimuli and lipopolysaccharide activation
was ineffective in inducing tumor necrosis factor a or interleukin 10 production. CB1 cells,
pulsed with haptens in vitro and injected into naive mice were able to induce delayed-type
hypersensitivity responses, further increased with pretreatment with GM-CSF, indicating that
these cells may represent an immature, rather than a mature DC. The ability of CB1 to prime
T cells in vivo could provide a tool to design novel immunization strategies.
D
endritic cells (DC)1 , first described by Steinman and
Cohn in 1973 (1), are a populationof widely distributed
leukocytes that play a key role in the immune system (2, 3)
given that they are: (a) highly specialized in antigen presen-
tation; (b) the principal activators of resting T cells in vitro
(4, 5); (c) the major source ofimmunogenic epitopes for specific
T cell clones after administration of antigen in vivo (6, 7)
and (d) the most potent initiators of primary T cell-medi-
ated responses in vivo (8).
Several studies (2, 3) have suggested that DC provide naive
T cells with all the necessary signals required for activation
1 Abbreviations used in this paper . CI, chemotaxis index; CS, contact
sensitivity; DC, dendritic cell; DNBS, 2,4-dinitro benzene sulfonic acid;
DTH, delayed-typehypersensitivity; fmlp, formyl peptide; HSA, heat stable
antigen; ICAM-1, intracellular adhesion molecule 1; MCP-1, macrophage
chemotactic protein 1; MIP-la, macrophage inflammatory protein la;
PAF, platelet-activating factor; PI, phagocytosis index; rm, recombinant
mouse; SpWMb, spermwhale myoglobin.
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and proliferation. These signals are generated by the interac-
tion of complexes of MHC molecules and antigenic peptides
with the TCR (9), and by the engagement ofcostimulatory
molecules, including binding ofB7/BB1 molecules on APC
to CD28 receptor on the T cell surface (10, 11) . The first
signal alone elicits effector functions only in activated T cells
and is unable to stimulate naive or resting T cells, which in
the absence of costimulatory signals can enter a period of
unresponsiveness (12-14). The expression of the costimula-
tory molecule B7/BB1 on DC populations has been recently
reported and shown to be critical in DC-driven primary T
cell responses (15-17) .
Understanding the mechanisms underlying the potent
stimulatory capacities of DC could explain how T cells are
primed and how the immune response is initiated. With this
knowledge one might try to manipulate immune responses
at very early stages and provide a way for inducing immu-
nity or tolerance. However, an important limitation in the
study of DC biology has been the small numbers of cells
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are clearly similar to DC have been obtained so far. Three
different tissues have been used as major sources ofDC: mouse
spleen, the epidermis, where DC are known as Langerhans
cells, and human blood. In each case DC constitute a tiny
fraction of the starting tissue, representing about 1% of crude
spleen (18) or epidermal (19, 20) cell suspensions and 0.1-1%
of PBMC (21). More recently, Inaba et al. (22) have described
a method for generating DC from both peripheral blood and
bone marrow precursors, but cell proliferation ceases within
1-3 wk.
A different approach is to generate cell lines of DC. Ear-
lier studies from our laboratory (23, 24) have shown that,
using a mixture ofrecombinant retroviruses transducing the
avian v-myCMH2 oncogene, the immortalization of macro-
phages could be readily achieved from several different tissues.
The immortalized and cloned macrophages were shown to
respond in a physiological way to activation signals and were
able to exert all the expected functions of macrophages (25).
The retroviral recombinant genome was molecularly cloned
and transfected into the 02 packaging cell line. The novel
MIB~2-N11 helper-free retrovirus was then used to infect
mouse spleen primary cultures (Sassano, M., F. Granucci, P.
Paglia, M. Foti, and P Ricciardi-Castagnoli, manuscript sub-
mitted for publication). With this approach, immortalized
DC lines were also generated. One clone, named CB1, was
extensively characterized and shown to possess many of the
features described for DC, including the expression ofB7/BB1,
heat stable antigen (HSA), intracellular adhesion molecules
1 (ICAM-1), and the reactivity with several anti-DC mAbs.
The stimulatory capacity of the CB1 clone was shown in
vitro, both in primary MLR and in antigen-specific T cell
proliferative assay. GM-CSF increased the constitutive MHC
class II molecule expression and was essential for antigen-
specific APC activity in vitro. In addition, CB1 cells pulsed
in vitro with haptens were able to induce a delayed-type hyper-
sensitivity (DTH) immune response, thus indicating that T
cell priming can be achieved using an antigen-loaded cell line
as natural adjuvant.
Materials and Methods
Generation ofDendritic Cell Lines.
￿
Spleen cell suspensions were
prepared from newborn DBA/2 mice (Charles River, Como, Italy)
in RPMI-1640 (Sigma Chemical Co., St. Louis, MO) supplemented
with 10% FCS (GIBCO BRL, Gaithersburg, MD), glutamine,
penicillin-streptomycin, and 0.5 mM /3-ME. RBC were lysed and
spleen cells were seeded at 106/ml density in 35-mm petri dishes.
Immortalization was carried out with the MIB-0N11 retroviral
vector generated by transfection ofthe packaging cell line 02 with
a molecularly cloned recombinant retrovirus (Sassano, M. et al.,
manuscript submitted for publication). This recombinant retrovirus
was originally obtained by transfection of mouse fibroblasts with
the avian MH2 and the mouse AKRv viral genomes and resulted
in recombinant retroviruses carrying the gag, pol, env genes and
LTR of AKRv and the avian v-myc"z oncogene (23-25).
Infection with MIB02-Nll was performed with filtered super-
natant from a 24-h subconfluent culture of the viral producer cell
line ON11 diluted 1:1 with complete medium containing 10 p,g/ml
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polybrene (Sigma Chemical Co.). After 1 h incubation at 37°C
in a 5% COz incubator, half volume offresh medium was added
and then regularly changed twice a week. During the first week
after infection, cells were fed with 10% L929.6C-conditionedmedia,
reduced at 5% in the following 2 wk, and than gradually elimi-
nated.
About 20-30 d after infection, multiple foci of dividing cells
were observed in the petri dishes. Cultures could then be tryp-
sinized and cells replated. The cell line was considered established
after 10 passages, and then cloned by limiting dilution.
Immunostaining Analysis of CBI Cells.
￿
Cell surface expression
ofleukocyte markers was assessed using the following mAbs: M1/9.3
(TIB 122), RA.3.3.A1(TIB 146), F4/80 (HB198), 2AG2 (BB 197),
FD 441.8 (TIB 213), Ml/70 (TIB 128), M1/42 (TIB 126), 33DI
(TIB 227); NLDC145, B5 .5, RB6-8C5, B21-2, M1/69 (kindly
provided by R. M. Steinman, The Rockefeller University, New
York), and FAII, 3D6 (kindly provided by S. Gordon, Oxford
University, Oxford, UK), 1G10 (PharMingen, San Diego, CA),
followed by anti-rat Ig-FITC (Boehringer Mannheim, Mannheim,
Germany); N418 (HB224), 145-2C11, 3E2, H57-597 (Phar-
Mingen), followed by anti-hamster Ig-PE (Southern Biotechnology
Associates, Birmingham, AL), biotinylated MK-D6,39-10-8, AMS-
16, IM7, RM2-5, RM4-5, 53-6.7, RA3-6132, 34-2-12 (Phar-
Mingen) mAbs, followed by Streptavidin-PE (Sigma Chemical Co.).
Purified Igs (PharMingen) or unrelated isotype-matched Abs were
used as controls.
CB1 cells (5 x 105) were incubated for 30 min at 4°C with
hybridoma supernatants, affinity purified or biotinylated primary
mAbs followed by either anti-rat Ig-FITC or anti-hamster Ig-PE,
or Streptavidin-PE. For MHC class II expression, cells were stained
before and after 48-h treatment with either 100 U/ml of recom-
binant mouse (rm) IFN-'Y or 200 ng/ml ofrmGM-CSF (Genzyme
Corp., Cambridge, MA) .
Analysis was performed on FACScan® cytofluorimeter (Becton
Dickinson & Co., Mountain View, CA) after dead cells removal
by propidium iodide gating.
Peroxidase immunostaining ofCB1 cells was carried out to show
reactivityfor intracellular antigens recognized by the rat anti-DC
mAbs 2A1 (26) and by the hamster anti-DC M342 (27) kindly
provided by N. Romani (University ofInnsbruck, Innsbruck, Aus-
tria). CBl cells were grown on coverslipsand fixedin cold acetone.
Cells were incubated for 1 h with mAbs in the presence of 1%
normal mouse serum, washed and stained with peroxidase mouse
anti-hamster (Pierce, Rockford, IL) or anti-rat Ig (Boehringer
Mannheim), and visualized using diaminobenzidine as substrate
(Sigma Chemical Co.).
Adherence, Phagocytosis, Chemotaxis, and Cytokine Production.
Phagocytic ability was assessed using zymosan particles either un-
treated or opsonized with normal mouse serum. Phagocytosis index
(PI) was evaluated at the microscope. Chemotaxisindex (CI) was
kindly measured by P. Sacerdote (University of Milan) in response
to 10 -' M formyl peptide (fmlp), 10 ng/ml macrophage
chemotactic protein (MCP-1) or 10 -1° M platelet activating factor
(PAF). TNF-cx secretion was measured by ELISA according to the
suggestions of the supplier (Genzyme Corp.). IlrlO secretion was
kindly measured by P. Gnocchi (Farmitalia-Carlo Erba, Nerviano,
Italy) with a RIA method previously described (28).
Northern BlotAnalysis.
￿
Northern blot analysis ofmRNAs from
CBl cells and a positive control was carried out using a specific
MYCMHZ probe previously described (25). The myCMH2 3' probe was
derived from a chicken genomic library and it represents the 3' re-
gion of the avian myc gene which does not crosshybridize with
the murine myc genes.
Immortalized Dendritic Cell Line Initiates Primary T Cell ResponsesExpression ofB7/BB1 Molecule.
￿
mRNA (polyA)' from LPS-
activated splenocytes, LPS-activatedA20 cells, and untreated CB1
cellswas prepared from 5 x 106 cells. Activation was carried out
for 72 h with 10 p .g/ml of LPS (Escherichia coli, B5:055 ; Sigma
Chemical Co .) . First strand cDNA synthesis was obtained using
AMVreverse transcriptase (Promega Corp., Madison,WI) andan
oligo dT primer. PCR was performed in a 50-p,1 vol using 2.5 Al
cDNA, 5Al 10x PCRbuffer (Perkin ElmerCorp ., Norwalk, CT),
1.5 mM Mg", 0.25 mM dNTPs, 1.5 U Taq polymerase
(Boehringer Mannheim), and 25 pmol forward and reverse oligo-
nucleotide primer. Nucleotides 249-266 and 1153-1169 of the
B7/BB1 cDNA sequence were used as sense and antisense oligo-
nucleotides, respectively, as previously described (15) . PCRcondi-
tions were 40 cycles using a thermocycler (Perkin-Elmer Corp .) :
1 min, 95°C; 45 s, 56°C; 1 min, 72°C. PCRproducts were ana-
lyzed by agarose gel electrophoresis and blotted to nylon mem-
brane. Southern blot was probed with an internal B7/BB1 oligo-
nucleotide (nucleotides 661-680) as described (15) .
In Vitro T Cell Stimulatory Capacity ofCBI Cells .
￿
In an antigen-
specific presentation assay, 105 CB1 or MT2 cells, treated with ei-
ther 100U/ml IFN--y or 200 ng/mlrmGM-CSF, or A20 cells, were
used as APC for spermwhale myoglobin (SpWMb, 0-5 AM) to
10" antigen-specific T hybrid cells (13.26.8 H6 .1 SpWMb-specific
H-2d restricted T cells were kindly provided byA . M . Livingstone,
Basel Institute of Immunology, Basel, Switzerland) . Antigen, at
the indicated doses, was present during all the time of the assay .
After 24 h of incubation, 100 Al of supernatant was transferred
and tested for the IL-2 content on the HT.2 cell line (5 x 103
cells/well) . Proliferation was measured using the MTT assay. In
aMLR assay, GM-CSF treated or untreated dendriticCB1 cell line
andMT2/1 macrophage cell line (23) were treated with mytomycin
C (4,ug/ml) and used, at the indicated doses, as stimulators in cocul-
ture with 3 x 105 allogeneic C57BL/6T cells as responders . Syn-
geneic T cells were also used as controls. T cells were the nonad-
herent spleen cells purified on nylon wool columns . [3H]TdR
incorporation (2.5 p .Ci/ml) was measured 72 h later.
Induction ofContact Sensitivity .
￿
Contact sensitivity wasinduced
by injection of 2,4-dinitro benzene sulfonic acid(DNBS;Eastman
Kodak, Rochester, NY)-modified or FITC-modified CB1 cells
pretreated or notwithGM-CSF (200 ng/ml) . CB1 cells were deriva-
tized with either 200 Ftg/ml of FITC (Sigma Chemical Co .) or
with 1 mg/ml DNBS for 30 min at 37°C as described (29, 30)
and inoculated subcutaneously into the dorsal skin ofDBA/2mice.
Each mouse received 10"-105 cells suspended in HBSS in a final
vol of 250AL Recipient mice and nonsensitized controls were ear
challenged 5d later with either 25pg FITC or 15 hg of 2,4-dinitro-
1-fluorobenzene(DNFA SigmaChemical Co .) on each side ofboth
ears. Mice sensitized epicutaneously were painted with 150 Ag
DNFB or 2 mg FITC on the shaved abdomen, as described (29,
30) . Ear thickness was measured with an engineer's micrometer.
Results
Generation o .fDendritic Cell Lines.
￿
Spleen cell suspensions
from newborn mice were infected with the retroviral vector
MIB~2-N11. About3wk after infection, foci were observed
and proliferating cells, detaching from adherent aggregates,
were easily cloned . Among several clones obtained, theclone
namedCB1 was selected because of its dendriticmorphology.
Fig . 1 shows typical aggregates ofproliferatingCB1 cells with,
at the periphery of the clusters, cells possessing a dendritic
appearance. Characteristically, these cells display sheetlike
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Figure 1 .
￿
Morphological appearance of the cell line CB1 (phase con-
trast microscopy). Clusters ofCB1 cells 48 h after seeding: at the periphery
of the clusters, cells with a dendritic phenotype are observed .
processes, with a striking motility when observed at video
microscopy (datanot shown) . This behavior is not exhibited
by other leukocytes and may have a functional significance
in the survey of T cells (2, 3) .
The estimated doubling time of CB1 cell line was about
20h(datanot shown) . Productive viral infectionofCBI cells
with the MIB02-N11 retroviral vector (described in Fig. 2
a) was tested by Northern blot analysis using a specific
mycMHZ probe (31) : genomic and subgenomic transcripts of
the expected size were detected (Fig . 2 b) .
In addition to spleen, other tissues have been infected with
the MIBtfi2-N11 retroviral vector. From infected cultures of
bonemarrow and skin tissuesDC-like cell lines were gener-
ated (Paglia, P., manuscript in preparation) . Moreover, from
Figure 2 .
￿
(a) TheMIB-ON11 proviral genome. Viral immortalization
with theMIB-ON11 retroviral vector : Northern blot analysis ofCB1 cells
(A) and of a positive control (B) probed with a specific mycMHZ probe.
(b) The genomic andsubgenomic transcripts with the expected size (ar-
rowheads) .BALB/c spleen cultures, one additional dendritic cell line
(D2SC/1) was established and extensively characterized (Paglia,
P., manuscript in preparation), thus showing the reproduci-
bility of the method.
CBI Cell Line Has Many ofthe Features ofSplenic DC.
Cytofluorometric cell surface analysis with severalmAbs (Fig .
3) and intracellular staining with the M342 (27) and the 2A1
(26) (Fig . 4) revealed a characteristic DC immunophenotype
of theCB1 cell clone. CB1 cells express high levels ofMHC-I
molecules, of thecommon leukocyte antigen CD45, the adhe-
sion molecules Pgp-1 (CD44) and CD11c, the latter shown
to be a typical marker of spleen DC (32) . A bright staining
was also achieved with mAbs against B7/BB1, HSA, and
ICAM-1 costimulatory molecules. Intermediate levels of ex-
pression were detected for 33D1, NLDC-145, FA11 antigens
and LFA-1 and MAC-1 integrins. Moreover, CB1 cells lack
M C-II
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Figure 3 .
￿
Cytofluorimetric analysis of CB1 cells stained with a set of
mAbs (described in Materials and Methods) recognizing various deter-
minants specific for T and B lymphocytes, macrophages, granulocytes, and
DC .
the B cell marker B220 and are negative for T cell-specific
determinants : Thy1, CD3-e, TCR, CD4, and CD8 . These
results are in agreement with those reported for spleen DC
(26) and Langerhans cells (20, 33) . Low levels of F4/80 and
Fcy-RII were present on CB1 cell surfaces ; however, com-
paring CB1 cells with macrophage MT2 cells we found that
expression of F4/80 and Fcy-RII was fivefold higher onMT2
cells (data not shown) . Finally, we detected high CD2 ex-
pression onCB1 cell surface. This result was unexpected and
is intriguing because it suggests that homotypic interactions
between DC and T cells may occur.
MHC-II expression on CB1 cells treated or untreated with
GM-CSF was tested using a panel ofanti-MHC mAbs recog-
nizing various epitopes ofI-A or I-E molecules. ThesemAbs
(MK-D6, B21-2, 39-10-8, and AMS-16) detected constitu-
tive expression of MHC-II molecules on CB1 cells with a
high degree of variability (from low to high) depending on
the mAb used (data not shown) . Interestingly, in all cases
the expression ofMHC-II molecules was enhanced whenCB1
cells were treated with GM-CSF. In contrast, IFN-y did not
exert any influence on MHC-II expression on CB1 cells,
whereas it was effective in inducing both I-A and I-E expres-
sion on MT2 macrophage cell line (data not shown) .
Taken as a whole these results suggest that CB1 cells may
represent an immature splenic DC precursor still responsive
to GM-CSF .
Functional Properties ofCB1 Cells.
￿
Spleen DC are loosely
and transiently adherent to plastic surfaces (1-3) ; similarly,
Figure 4.
￿
Immunostaining of CBI cells. Peroxidase immunostaining
of CB1 cells showing reactivity for intracellular antigens recognized by
the anti-DC mAbs 2A1 (A) and M342 (C) compared with the corre-
sponding isotyped-matched control Ab (B and D) .
LFA-1 1 HSA 07 C38i-R
Immortalized Dendritic Cell Line Initiates Primary T Cell ResponsesCB1 cells were loosely adherent and pipetting was enough
to detach them . Compared to macrophages (MT2/1 cells)
which can be detached only in the presence of trypsin, CB1
cells were very much less adherent (Table 1) .
Phagocytic and chemotactic activities were also tested . DC
are known to be not actively phagocytic (2, 3) and, consis-
tent with this, CB1 cells exhibited very little zymosan phago-
cytosis, whereas MT2/1 macrophages showed a strong phago-
cytic ability (Table 1) .
Chemotaxis was measured in response to fmlp, MCP-1,
and PAR CBl cells did not respond to any of these stimuli,
even if previously activated with LPS or GM-CSF, whereas
MT2/1 macrophages were able to migrate in response to all
stimuli (Table 1) . This finding is of particular interest since
it suggests that DC have chemotactic and migratory proper-
ties different from those of macrophages .
Controversial results have been reported concerning the
production of cytokines by different DC . Spleen DC have
been shown to produce little or no IL-1 when activated with
a variety of stimuli (34) . In contrast, epidermal Langerhans
cells have been identified as the major source ofmRNA for
IL-10 and macrophage inflammatory proteins, MIP-1a and
MIP-2, among unstimulated and hapten-activated epidermal
cells, with a strong upregulation of the former upon short-
Table 1 . Adherence, Phagocytosis, Chemotaxis, and
Cytokine Production by CBI and MT2/1 Cell Lines
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term culture (35-38) . In contrast to MT2/1 macrophages,
CB1 cells were shown to produce very small amounts of
TNF-ac and IL-1(3 upon stimulation with LPS (Table 1),
confirming at a clonal level previous negative results on IL-1
expression by enriched spleen DC preparations (34) .
Expression ofthe Costimulatory Molecule B7/BB1 .
￿
APC need
to provide two different signals in order to activate T lym-
phocytes : an antigen-specific interaction and accessory
nonspecific signals . Recently, the costimulatoryB7/BB1 mol-
ecule has been identified on APC (10, 11, 39, 40) and has
proven to be essential for proliferation of unprimed allogeneic
T cells inMLR assay and CD4+ T cells in antigen-specific
proliferative responses (15, 16) .
Spleen DC express constitutively the B7/BB1 molecule (15,
16) whereas the A20 cell line or B cells require activation
by LPS or through cross-linking of either surfaceMHC class
II molecules (41) or their cytoplasmic domain (11) .
Transcription of the B7/BB1 gene was evaluated in LPS-
activated splenocytes, in A20 cells, and in CB1 DC . PCR
analysis was carried out using sense and antisense oligonu-
cleotides derived from the murine B7/BB1 cDNA sequence
(40, 42) . PCR products are shown in the upper part of Fig .
5 . Only CB1 cells have a constitutive transcription of the
B7/BB1 gene whereas in A20 cells and in splenocytes tran-
scription was induced only after treatment withLPS. To show
specificity,PCR products were also analyzed in Southern blots
(Fig . 5, bottom) probed with an internal B7/BB1 oligonu-
cleotide. Cell surface expression ofthe protein was confirmed
by cytofluorimetric analysis using the 1G10mAb (11) which
recognizes the mouse B7/BB1 molecule (Fig . 3) .
Induction ofT Cell Responses In Vitro and In Viva
￿
Fresh
DC pulsed in vitro with native protein antigens or peptides
can very efficiently stimulate antigen-specific primed and naive
CD4+ T cells (5, 12, 20, 43) . In agreement with these
reports, we found that a native protein such as SpWMb was
presented by CB1 cells to specificT cell hybrids after incuba-
tion withrmGM-CSF (Fig. 6) . The enhanced APC function
induced by GM-CSF paralleled the GM-CSF-mediated in-
duction ofMHC-II molecules described above . GM-CSF in-
ducibility ofMHC-II molecules and accessory functions has
been described in precursors ofDC (44), strongly suggesting
that CBl cells may represent an intermediate stage of DC
maturation .
Figure 5 .
￿
Expression of B7/BB1 . (Top)
Analysis ofPCR products from untreated (A)
or LPS-activated splenocytes (B), untreated
(C), or LPS-activated A20 cells (D), and un-
treated CB1 cells (E) . (Bottom) Southern blot
analysis ofPCR products hybridizedwith an
internal B7/BB1 oligonucleotide . LPS-
activated splenocytes (B), LPS-activated A20
cells (D) and untreated CB1 cells (E) .
Functions Stimuli Cell line Activity
Adherence to MT2/1 + + +
Plastic surface
CB1 +
Phagocytosis Zymosan MT2/1 + + + (89 PI)
CB1 +/- (5 PI)
Chemotaxis fmlp MT2/1 + (3.6 CI)
PAF + + (6 .7 CI)
MCP-1 + + + (11 CI)
fmlp CB1
PAF
MCP-1
Cytokine LPS MT2/1 TNF-a (3 .0
production ng/ml)
IL-1/3 (5 .0
ng/ml)
LPS CBI TNF-a (0.4
ng/ml)
IL-10 (0.2
ng/ml)160
140
120
100
a 80
0
n~ 60 a
40
20
Figure 6 .
￿
In vitro T cell stimulatory capacity ofCB1 cells: antigen pre-
sentation . CB1 cells, treated with either 100 U/ml IFN-.y ("--" ), 200
ng/ml mrGM-CSF ("), or A20 cells (O--O) were used as APC for
SpWMb to antigen-specificT hybrid cells (13.26.8H6 .1 SpWMb-specific
H-2a-restricted T cells) . 11,2 production was measured on theHT.2 cell
line using the MTT assay.
A strong stimulating activity ofDC in the primary MLR
has been known since 1978 (45) . We compared the stimula-
tory capacity ofCB1 and MT2/1 macrophages in a primary
dose-response MLR assay. As shown in Fig. 7, CB1 cells
possess accessory function in the in vitro allogeneic T cell
proliferative assay. This response does not have the expected
amplitude typical of fully differentiated DC, but this may
again reflect the immature state ofCB1 cells . Antigen-pulsed
DC, but not other APC such as B cells or macrophages, can
be administered in vivo to primeT lymphocytes without ad-
ditional adjuvants . DC are considered the most potent initi-
ators of various primary T cell-mediated responses in vivo
such as contact sensitivity (CS) (46), allograft rejection (8,
47), and activation ofMHC-restrictedT cells (6, 7) . Moreover,
it has been shown that antigen-pulsedDC are able to induce
an Ab response in vivo (48) . The ability ofCB1 cells to prime
NO
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Figure 7 .
￿
In vitro T cell stimulatory capacity ofCB1 cells : MLR assay.
Graded doses of CB1 ("-i) and MT2/1 (O--O) cells were used as stimu-
lators in coculture with 3 x 10 5 allogeneic C57BL/6 T cells as responders .
Incubation of 3 x 104 CB1 cells with 3 x 10 5 syngeneicT cells resulted
in 550 cpm [3H]TdR uptake (background level) .
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T cells in vivo was tested in the model of CS to haptens.
CS is a particular type of delayed-in-time, T cell-mediated
immune reaction occurring after epicutaneous immunization
and challenge with reactive haptens (29, 46) . Crucial to the
development of CS reactions are epidermal Langerhans cells
(30) . CS also results when Langerhans or lymphoidDC are
conjugated in vitro to haptens and injected into syngeneic
mice (29, 46, 49) .
CB1 cells modified in vitro with either FITC or DNBS
and injected subcutaneously into naive syngeneic mice were
able to induce CS responses, indicating that CB1 cells can
sensitize T lymphocytes in vivo. In contrast, injection of
nonhapten-conjugatedCB1 cells did not induce any significant
ear swelling response (Fig. 8) . The efficiency of CB1 cells
to induce CS was increased when cells were pretreated for
48 h with GM-CSF (Fig . 9) .
Discussion
The potential use of elements of the immune system to
prime naive animals offers great advantages over standard im-
munizations with artificial adjuvants . The "dirty trick ofim-
munologists", as stated by CharlesA . Janeway, Jr. (50), which
consists o£ the addition ofmineral oil or killed bacteria (CFA)
to highly purified or recombinant protein antigens to ini-
Immunization
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Figure 8 .
￿
Induction of contact sensitivity by injection of DNBS- or
FITC-modified CB1 cells . 10 4-105 CB1 cells were derivatized with either
FITC or withDNBS for 30 min at 37`C, and inoculated subcutaneously
into the dorsal skin of DBA/2 mice. Recipient mice and nonsensitized
controls were ear challenged 5 d later with either FITC orDNFB on each
side ofboth ears. Mice sensitized epicutaneously werepainted withDNFB
or with FITC on the shaved abdomen . Ear thickness was measured with
an engineer's micrometer immediately before challenge and 24, 48, and
72 h after challenge. Data are expressed as the change (from prechallenge
levels) in ear thickness x 10 -4 inches and represent the mean maximal
increase within the 72-h observation period (n = 4) .
Immortalized Dendritic Cell Line Initiates Primary T Cell ResponsesFigure 9.
￿
Induction of contact sensitivity by injection of DNBS- or
FITC-modified CB1 cells (50,000) activated with GM-CSF. The proce-
dure is the same as in Fig. 8, except that CB1 cells were pretreated or
not for 48 h with 200 ng/ml GM-CSF before hapten derivatization.
tiate an immune response, can be overcome . Now we know
that unprimed T lymphocytes recognize antigenic epitopes
expressed on the cell surface of DC which possess all the
costimulatory signals (e.g ., B7/BB1, ICAM-1, LFA-3, and
HSA) necessary for T cell proliferation and differentiation
(2, 3, 5, 11) . Moreover, priming with antigen-pulsed DC
can also elicit amemory immune response. DC can thus be
considered, as suggested by Ralph Steinman, "nature's adju-
vants" (2, 12) that can initiate in vivo both cell-mediated
(DTH) and T cell-dependent Ab responses (3, 48) .
In this paper we show the generation of a DC line using
a novel retroviral vector, MIB~2-N11, transducing an acti-
vated env^KR-mycMH 2 fusion gene. The established DC line,
CB1, was shown to possess many ofthe phenotypic features
oflymphoidDC, including expression ofthe B7/BB1, HSA,
and ICAM-1 molecule .
The GM-CSF inducibility of class II expression in CB1
cells might mean that these cells represent a DC precursor,
rather than a mature DC . The observation that bonemarrow
and blood DC precursors derive from Ial cells (26, 44) sup-
ports this hypothesis. In addition, immature DC, including
freshly isolated epidermal Langerhans cells, express lower levels
of class II molecules compared to a fully differentiated DC
(2, 3, 51) .
Functionally, CB1 exhibited both the ability ofprocessing
and presenting native protein antigens in vitro as well as the
function of sensitizingT cells in vivo, as assessed by the ability
to initiate a primary DTH response.
GM-CSF-increased expression ofMHC class II molecules
was necessary for the in vitro antigen-specific APC activity
ofCB1 cells, and enhanced the ability ofCB1 cells to induce
CS, confirming a key role of GM-CSF in the differentiation
and activation ofDC accessory functions. GM-CSF was also
shown to support the growth and differentiation ofDC from
mouse blood or bonemarrow cultures (22) and ofearly human
cord blood and bone marrow progenitors into DC (51) . In
addition, GM-CSF in cooperation with TNF-a, promotes
the in vitro differentiation of epidermal Langerhans cells into
matureDC (2, 3, 52), and induces generation ofLangerhans
cells from human cord blood CD34+ precursors (53) .
Moreover, our results add further evidence to the notion
that DC and macrophages can be distinguished for a variety
of properties, including morphology, immunophenotype,
phagocytosis, response to chemotactic stimuli, cytokine
production profile, and cytokine activation requirements. It
has been shown thatAPCs produce a limitednumber of pre-
dominant immunogenic peptides and thatDCmake the most
immunogenic ligands for antigen-specificTCR (2, 3) . In this
regard, theCB1 cellline could be used to probe the immunoge-
nicity of various antigens among which tumor-associated an-
tigens are the most relevant candidates .
The stimulatory function of the DC line CB1 could also
provide a tool to design novel immunization strategies . The
role played by the route of administration, the organ where
antigen presentation occurs, and the type ofimmune response
elicited are questions that can now be addressed using in all
experiments the same clonal population of DC.
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